Ken Fisher Ligand Pharmaceuticals Inc Transaction History

Fisher Asset Management, LLC

$229 Billion
Q2 2024

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 53,019 shares of LGND stock, worth $5.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,019

Previous 53,377 0.67%

Holding current value

$5.39 Million

Previous $3.9 Million 14.51%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$68.53 - $87.91 $24,533 - $31,471	-358 Reduced 0.67%	53,019 $4.47 Million
Q1 2024 May 09, 2024	BUY	$68.64 - $89.2 $280,051 - $363,936	4,080 Added 8.28%	53,377 $3.9 Million
Q4 2023 Feb 06, 2024	BUY	$49.57 - $72.63 $794,854 - $1.16 Million	16,035 Added 48.21%	49,297 $3.52 Million
Q3 2023 Nov 13, 2023	SELL	$58.86 - $72.67 $150,858 - $186,253	-2,563 Reduced 7.15%	33,262 $1.99 Million
Q2 2023 Dec 12, 2023	BUY	$69.53 - $79.33 $178,205 - $203,322	2,563 Added 7.71%	35,825 $2.58 Million
Q2 2023 Aug 08, 2023	SELL	$69.53 - $79.33 $294,946 - $336,517	-4,242 Reduced 10.59%	35,825 $2.58 Million
Q1 2023 Dec 12, 2023	BUY	$65.67 - $77.08 $435,917 - $511,657	6,638 Added 19.96%	39,900 $2.94 Million
Q1 2023 May 01, 2023	BUY	$65.67 - $77.08 $26,859 - $31,525	409 Added 1.03%	40,067 $2.95 Million
Q4 2022 Feb 03, 2023	BUY	$61.72 - $96.74 $701,632 - $1.1 Million	11,368 Added 40.18%	39,658 $2.65 Million
Q3 2022 Nov 08, 2022	BUY	$0.01 - $107.56 $208 - $2.24 Million	20,859 Added 280.7%	28,290 $2.44 Million
Q2 2022 Aug 09, 2022	SELL	$74.52 - $117.06 $2,980 - $4,682	-40 Reduced 0.54%	7,431 $663,000
Q1 2022 May 05, 2022	BUY	$94.99 - $151.56 $3,799 - $6,062	40 Added 0.54%	7,471 $840,000
Q4 2021 Feb 02, 2022	SELL	$127.69 - $165.85 $383 - $497	-3 Reduced 0.04%	7,431 $1.15 Million
Q3 2021 Oct 26, 2021	BUY	$102.33 - $144.73 $121,875 - $172,373	1,191 Added 19.08%	7,434 $1.04 Million
Q2 2021 Jul 27, 2021	BUY	$113.03 - $155.64 $25,431 - $35,019	225 Added 3.74%	6,243 $819,000
Q1 2021 Apr 27, 2021	SELL	$99.52 - $215.83 $6.11 Million - $13.3 Million	-61,429 Reduced 91.08%	6,018 $917,000
Q4 2020 Jan 29, 2021	SELL	$80.55 - $106.05 $205,241 - $270,215	-2,548 Reduced 3.64%	67,447 $6.71 Million
Q3 2020 Nov 10, 2020	SELL	$89.56 - $126.72 $397,915 - $563,016	-4,443 Reduced 5.97%	69,995 $6.67 Million
Q2 2020 Aug 07, 2020	SELL	$68.28 - $123.65 $266,838 - $483,224	-3,908 Reduced 4.99%	74,438 $8.33 Million
Q1 2020 Apr 28, 2020	SELL	$63.37 - $107.88 $543,777 - $925,718	-8,581 Reduced 9.87%	78,346 $5.7 Million
Q4 2019 Feb 12, 2020	SELL	$96.94 - $113.59 $1.09 Million - $1.28 Million	-11,271 Reduced 11.48%	86,927 $9.07 Million
Q3 2019 Oct 29, 2019	BUY	$86.25 - $120.16 $1.1 Million - $1.53 Million	12,750 Added 14.92%	98,198 $9.78 Million
Q2 2019 Jul 30, 2019	BUY	$107.38 - $129.34 $1.47 Million - $1.77 Million	13,692 Added 19.08%	85,448 $9.75 Million
Q1 2019 Apr 22, 2019	BUY	$105.93 - $142.47 $598,610 - $805,097	5,651 Added 8.55%	71,756 $9.02 Million
Q4 2018 Jan 25, 2019	BUY	$128.36 - $272.13 $3.01 Million - $6.39 Million	23,486 Added 55.11%	66,105 $8.97 Million
Q3 2018 Oct 24, 2018	SELL	$211.18 - $274.49 $446,645 - $580,546	-2,115 Reduced 4.73%	42,619 $11.7 Million
Q2 2018 Jul 09, 2018	SELL	$150.77 - $207.98 $329,281 - $454,228	-2,184 Reduced 4.65%	44,734 $9.27 Million
Q1 2018 May 11, 2018	SELL	$138.63 - $182.62 $9.83 Million - $13 Million	-70,939 Reduced 60.19%	46,918 $7.75 Million
Q1 2018 Apr 19, 2018	BUY	$138.63 - $182.62 $8.71 Million - $11.5 Million	62,796 Added 114.05%	117,857 $19.5 Million
Q4 2017 Jan 24, 2018	SELL	$128.36 - $147.04 $166,097 - $190,269	-1,294 Reduced 2.3%	55,061 $7.54 Million
Q3 2017 Oct 17, 2017	BUY	$120.91 - $137.94 $6.81 Million - $7.77 Million	56,355	56,355 $7.67 Million

Others Institutions Holding LGND

# of Institutions

247

Shares Held

17.5M

Call Options Held

61K

Put Options Held

7.8K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.72B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account